Your browser doesn't support javascript.
loading
Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells.
Hill, Kristen S; Schuler, Erin E; Ellingson, Sally R; Kolesar, Jill M.
Afiliación
  • Hill KS; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Schuler EE; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA.
  • Ellingson SR; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Kolesar JM; Division of Biomedical Informatics, UK College of Medicine, Cancer Research Informatics, University of Kentucky, Lexington, KY, USA.
Sci Rep ; 13(1): 22383, 2023 12 16.
Article en En | MEDLINE | ID: mdl-38104159
ABSTRACT
Artesunate is a derivative of artemisinin, an active compound isolated from Artemisia annua which has been used in Traditional Chinese Medicine and to treat malaria worldwide. Artemisinin derivatives have exhibited anti-cancer activity against both solid tumors and leukemia. The direct target(s) of artesunate are controversial; although, heme-bound proteins in the mitochondria have been implicated. We utilized computational modeling to calculate the predicted binding score of artesunate with heme-bound mitochondrial proteins and identified cytochrome c as potential artesunate target. UV-visible spectroscopy showed changes in the absorbance spectrum, and thus protein structure, when cytochrome c was incubated with artesunate. Artesunate induces apoptosis, disrupts mitochondrial membrane potential, and is antagonized by methazolamide in pediatric AML cells indicating a probable mechanism of action involving cytochrome c. We utilized a multi-disciplinary approach to show that artesunate can interact with and is dependent on cytochrome c release to induce cell death in pediatric AML cell lines.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Artemisininas / Antimaláricos Límite: Child / Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Artemisininas / Antimaláricos Límite: Child / Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos